SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $590,000 | -41.6% | 39,368 | -52.6% | 0.00% | -50.0% |
Q1 2016 | $1,011,000 | +103.8% | 83,071 | +166.6% | 0.00% | +100.0% |
Q4 2015 | $496,000 | +67.0% | 31,154 | +166.0% | 0.00% | – |
Q4 2013 | $297,000 | -84.8% | 11,713 | -87.8% | 0.00% | -100.0% |
Q3 2013 | $1,952,000 | – | 95,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |